Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit

Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit

ObjectivesTo investigate the prognostic significance of the systemic immune-inflammation index (SII) in patients after radical cholecystectomy for gallbladder cancer (GBC) using overall survival (OS) as the primary outcome measure.MethodsBased on data from a multi-institutional registry of patients...

Full description

Bibliographic Details
Main Authors: Lin Li, Tai Ren, Ke Liu, Mao-Lan Li, Ya-Jun Geng, Yang Yang, Huai-Feng Li, Xue-Chuan Li, Run-Fa Bao, Yi-Jun Shu, Hao Weng, Wei Gong, Wan Yee Lau, Xiang-Song Wu, Ying-Bin Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
gallbladder carcinoma
nomogram
systemic immune-inflammation index
chemotherapy
prognostic marker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.692647/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.692647/full

Similar Items